I greet my dear colleagues on the other side, the distinguished members of the Committee on the Judiciary, with a question or two that makes this anticounterfeiting act a little bit suspect. Now, there is nobody in the Congress supporting counterfeiting, but this legislation and its claim to help consumers by assisting in the recall of defective merchandise falls on its face, because the problem is, not only is this information already protected by current law, but the bill is not limited to products which implicate public health, nor is it limited to recall information. Instead, it covers any product sold in the country from books to perfume, and I think it is quite broad.
John Conyers: “I greet my dear colleagues on the other side, the distinguished members of the Committee on the Judiciary, with a…”
Editor's note · Context
Addressing concerns about the anticounterfeiting act during a House Judiciary Committee discussion.
Share
More from John Conyers
You got a good point, but we are going to be able to get it passed. Let's let it go to the courts.
We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufacturers to delay the entry of a version of branded drugs as the patent on the branded drug expires.
Since the Trump administration has come into being, briefing requests submitted by Democratic Members' staff have been repeatedly denied, ignored, or delayed.
The policies that I've just mentioned, that President Trump has repeatedly promised to deport 11 million, all 11 million undocumented immigrants.





